Kahn Brothers Group 13F, Q4 2025
Kahn Brothers · quarter ending 31 December 2025 · filed 12 February 2026 · SEC CIK 1039565
Common stock only: shares the fund reported owning at the quarter end, valued as filed.
Largest positions, Q4 2025
The 25 largest of 53 positions. Weights are against the whole filed book. Changes are in shares held, against the Q3 2025 filing.
| Company | Ticker | Value | % of book | vs Q3 2025 |
|---|---|---|---|---|
| Citigroup Inc | C | $102.25M | 18.1% | unchanged |
| Bayer AG Spons ADR | BAYRY | $73.08M | 12.9% | unchanged |
| Flagstar Financial, Inc. | FLG | $52.59M | 9.3% | -3% shares |
| Merck & Co. Inc. | MRK | $45.27M | 8.0% | unchanged |
| Walt Disney | DIS | $44.87M | 8.0% | unchanged |
| Alphabet Inc Class C | GOOG | $42.49M | 7.5% | unchanged |
| BP PLC | BP | $36.06M | 6.4% | -4% shares |
| Seaboard Corp | SEB | $32.38M | 5.7% | -6% shares |
| Organon & Co | OGN | $26.02M | 4.6% | unchanged |
| Idt Corp Class B | IDT | $20.07M | 3.5% | unchanged |
| Pfizer | PFE | $13.79M | 2.4% | -22% shares |
| Seaport Entmt Group Inc Com | SEG | $11.59M | 2.0% | unchanged |
| Bristol-Myers Squibb | BMY | $10.91M | 1.9% | -26% shares |
| Patterson Uti Energy | PTEN | $10.64M | 1.9% | -8% shares |
| GSK PLC ADR | GSK | $8.76M | 1.6% | -32% shares |
| M B I A Inc | MBI | $7.37M | 1.3% | unchanged |
| Genie Energy LTD Class B | GNE | $2.62M | 0.5% | unchanged |
| ExxonMobil | XOM | $2.43M | 0.4% | +13% shares |
| Fairfax Finl HLDGS LTD Sub VTG | FRFHF | $1.94M | 0.3% | unchanged |
| Novartis AG Sponsored ADR | NVS | $1.89M | 0.3% | -5% shares |
| Webster Finl Co | WBS | $1.88M | 0.3% | unchanged |
| First Natl BK Alaska Com | FBAK | $1.47M | 0.3% | unchanged |
| CSX Corp Com | CSX | $1.36M | 0.2% | -8% shares |
| Tourmaline Oil Corp Com | TRMLF | $1.21M | 0.2% | +10% shares |
| Microsoft | MSFT | $1.16M | 0.2% | +26% shares |
What changed since Q3 2025
Against the Q3 2025 filing, Kahn Brothers Group opened 0 new positions, added to 13, trimmed 15, left 25 unchanged and exited 0. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.
Other quarters
Source: SEC Form 13F-HR, accession 0001039565-26-000001, filed by KAHN BROTHERS GROUP INC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.